Corrigendum to "Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells" [Mol. Immunol. 44 (2007) 3416-3426] (DOI:10.1016/j.molimm.2007.02.022);Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells

Molecular Immunology

Volumn 44, Issue 13, 2007, Pages 3416-3426

  So, Eui Young ^a   Oh, Jiyoung ^a   Jang, Ji Young ^a   Kim, Jeong Ho ^a   Lee, Choong Eun ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Functional cross talk; IL 4; Jak1 Stat6; Ras Erk; Th cell differentiation

Indexed keywords

INTERLEUKIN 4; JANUS KINASE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; RAS PROTEIN; SMALL INTERFERING RNA; STAT6 PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UPREGULATION;

EID: 34247866415     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.09.006     Document Type: Erratum

References (53)

1. Agnello D., Lankford C.S., Bream J., Morinobu A., Gardina M., O'Shea J.J., and Frucht D.M. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23 (2003) 147-161
2. Berenson L.S., Ota N., and Murphy K.M. Issues in T-helper 1 development: resolved and unresolved. Immunol. Rev. 202 (2004) 157-174
3. Cantrell D. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14 (1996) 259-274
4. Dumont F.J., Staruch M.J., Fischer P., DaSilva C., and Camacho R. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. 160 (1998) 2579-2589
5. Egerton M., Fitzpatrick D.R., and Kelso A. Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes. Int. Immunol. 10 (1998) 223
6. Ho I.C., Hodge M.R., Rooney J.W., and Glimcher L.H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85 (1996) 973-983
7. Ip W.K., Wong C.K., and Lam C.W. IL-4 and IL-13 upregulate MCP-1 expression in human bronchial epithelial cells: involvement of p38MAPK, Erk1/2 and Jak2 but not JNK1/2 signaling pathways. Clin. Exp. Immunol. 145 (2006) 162-172
8. Jang J.Y., and Lee C.E. IL-4-induced upregulation of adenine nucleotide translocase 3 and its role in Th cell survival from apoptosis. Cell. Immunol. 241 (2006) 14-25
9. Johnston J.A., Wang L.M., Hanson E.P., Sun X.J., White M.F., Oakes S.A., Pierce J.H., and O'Shea J.J. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J. Biol. Chem. 270 (1995) 28527-28530
10. Jorritsma P.J., Brogdon J.L., and Bottomly K.J. Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J. Immunol. 170 (2003) 2427-2434
11. Kanai M., Konda Y., Nakajima T., Izumi Y., Kanda N., Nanakin A., Kubohara Y., and Chiba T. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Oncogene 22 (2003) 548-554
12. Kanda N., and Watanabe S. Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells. J. Immunol. 166 (2001) 72-80
13. Kaplan M.H., Schindler U., Smiley S.T., and Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4 (1996) 313-319
14. Kaplan M.H., Sun Y.L., Hoey T., and Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382 (1996) 174-177
15. Kopf M., Le Gros G., Bachmann M., Lamers M.C., Bluethmann H., and Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362 (1993) 245-248
16. Krasilnikov M., Ivanov V.N., Dong J., and Ronai Z. ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis. Oncogene 22 (2003) 4092-4101
17. Lederer J.A., Perez V.L., DesRoches L., Kim S.M., Abbas A.K., and Lichtman A.H. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184 (1996) 397-406
18. Lee C.E., Yoon S.R., and Pyun K.H. Mechanism of interferon-gamma down-regulation of the interleukin 4-induced CD23/Fc epsilon RII expression in human B cells: post-transcriptional modulation by interferon-gamma. Mol. Immunol. 30 (1993) 301-307
19. Lee D.U., and Rao A. Molecular analysis of locus control region in the T helper 2 cytokine gene cluster: a target for STAT6 but not GATA3. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16010-16015
20. Lee H.J., Takemoto N., Kurata H., Kamogawa Y., Miyatake S., O'Garra A., and Arai N. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 192 (2000) 105-115
21. Li-Weber M., Giasi M., and Krammer P.H. Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J. Biol. Chem. 273 (1998) 32460-32466
22. Lorentz A., Wilke M., Sellge G., Worthmann H., Klempnauer J., Manns M.P., and Bischoff S.C. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of Erk1/2 and c-Fos. J. Immunol. 174 (2005) 6751-6756
23. Mikhalkevich N., Becknell B., Caligiuri M.A., Bates M.D., Harvey R., and Zheng W.P. J. Immunol. 176 (2006) 1553-1560
24. Minshall C., Arkins S., Dantzer R., Freund G.G., and Kelley K.W. Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors. J. Immunol. 162 (1999) 4542-4549
25. Murphy K.M., and Reiner S.L. The lineage decisions on helper T cells. Nat. Rev. Immunol. 2 (2002) 933-944
26. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., and Paul W.E. The IL-4 recepor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17 (1999) 701-738
27. Nembrini C., Abel B., Koph M., and Marsland B.J. Strong TCR signaling TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells. J. Immunol. 176 (2006) 7180-7188
28. Nishikomori R., Usui T., Wu C.Y., Morinobu A., O'Shea J.J., and Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J. Immunol. 169 (2002) 4388-4398
29. Park H.J., So E.Y., and Lee C.E. Interferon-gamma-induced factor binding to the interleukin-4-responsive element of CD23b promoter in human tonsillar mononuclear cells: role in transient up-regulation of the interleukin-4-induced CD23b mRNA. Mol. Immunol. 35 (1998) 239-247
30. Park J.I., Strock C.J., Ball D.W., and Nelkin B.D. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol. Cell. Biol. 23 (2003) 543-554
31. Qian D., and Weiss A. T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 9 (1997) 205-212
32. Rhee J., Lee K., Kim D., Lee Y., Jeon O., Kwon H., and Kim D. NF-kB-dependent regulation of MMP9 gene expression by lipopolysaccharide in a macrophage cell line RAW264.7. J. Biochem. Mol. Biol. 40 (2007) 88-94
33. Rho H.S., Park S.S., and Lee C.E. Gamma irradiation upregulates expression of B cell differentiation molecule CD23 by NF-kB activation. J. Biochem. Mol. Biol. 37 (2004) 507-514
34. Rincon M. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13 (2001) 339-345
35. Robertson M.J., Chang H.C., Pelloso D., and Kaplan M.H. Impaired interferon-gamma production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma. Blood 106 (2005) 963-970
36. Sarkar A., and Franza B.R. A logical analysis of process of T cell activation: different consequences depending on the state of CD28 engagement. J. Theor. Biol. 226 (2003) 455-466
37. Skapenko A., Lipsky P.E., Kraetsch H.G., Kalden J.R., and Schulze-Koops H. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation. J. Immunol. 166 (2001) 4283-4292
38. Slavik J.M., Hutchcroft J.E., and Bierer B.E. CD28/CTLA-4 and CD80/CD86 families: signaling and function. Immunol. Res. 19 (1999) 1-24
39. So E.Y., Kim S.H., Park H.H., Cho B.S., and Lee C.E. Corticosteroid inhibits IL-4 signal thru down-regulation of IL-4 receptor and Stat6 activity. FEBS Lett. 518 (2002) 53-59
40. So E.Y., Park H.H., and Lee C.E. IFN-gamma and IFN-alpha posttranscriptionally down-regulate the IL-4-induced IL-4 receptor gene expression. J. Immunol. 165 (2000) 5472-5479
41. Song J.H., So E.Y., and Lee C.E. Increased serine phosphorylation and activation of STAT1 by oncogenic Ras transfection. Mol. Cells 13 (2002) 322-326
42. Staruschenko A., Patel P., Tong O., Medina J.L., and Stockand J.D. Ras activates the epithelial Na(+) channel through phosphoinositide 3-OH kinase signaling. J. Biol. Chem. 279 (2004) 37771-37778
43. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fauthman C.G., and Glimcher L.H. A novel transcription factor T-bet, directs Th1 lineage development. Cell 100 (2000) 655-669
44. Terada K., Kaziro Y., and Satoh T. Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line, BaF3. J. Biol. Chem. 270 (1995) 27880-27886
45. Wurster A.L., Tanaka T., and Grusby M.J. The biology of Stat4 and Stat6. Oncogene 19 (2000) 2577-2584
46. Yagi J., Arimura Y., Takatori H., Nakajima H., Iwamoto I., and Uchiyama T. Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naïve CD4+ T cells. Int. Immunol. 18 (2006) 1681-1690
47. Yamashita M., Kimura M., Kubo M., Shimizu C., Tada T., Perlmutter R.M., and Nakayama T. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 1024-1029
48. Yamashita M., Shinnakasu R., Asou H., Kimura M., Hasegawa A., Hashimoto K., Hatano N., Ogata M., and Nakayama T. Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. J. Biol. Chem. 280 (2005) 29409-29419
49. Yang D.D., Conze D., Whitmarsh A.J., Barrett T., Davis R.J., Rincon M., and Flavell R.A. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9 (1998) 575-585
50. Zamorano J., and Keegan A.D. Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. J. Immunol. 161 (1998) 859-867
51. Zhang S., and Kaplan M.H. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression. J. Immunol. 165 (2000) 1374-1380
52. Zheng W., and Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89 (1997) 587-596
53. Zhou M., and Quyang W. The functional role of GATA-3 in Th1 and Th2 differentiation. Immunol. Res. 28 (2003) 25-37